LUAD patients with higher TNM stage (stage III) and positive lymph node metastasis had significantly higher expression of TTN-AS1 than those with lower TNM stage (stages I and II) and negative lymph node metastasis (Table 1). The gene discussed is TTN; the disease is metastatic malignant neoplasm in the lymph nodes.